Drug intelligence / Profile preview

N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine

Development stage: Unknown
Modality: Small Molecules

Overview

N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine is an experimental small molecule compound belonging to the phenyl-1,2,4-triazole class. It has not been approved for any indication and is primarily studied in preclinical research. The compound acts as a potent inhibitor of serine/threonine-protein kinase pim-1 (PIM1), with a reported Ki of 11 nM. PIM kinases are implicated in cell survival and proliferation pathways and are considered potential targets in oncology drug discovery. No clinical trials or approved uses have been reported for this molecule[1][6].

Other names: N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine

Targets

PIM1 (Proviral integration site for moloney murine leukemia virus kinase 1)

Beyond the preview

Go deeper on N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine.

Explore the full profile